Investing Profile

Carlo Rizzuto

InvestorVC
Partner at Versant Ventures
Photo of Carlo Rizzuto, Partner at Versant Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
12
$102.2M
CompanyStageDateRound SizeTotal Raised
Nexo Therapeutics
Series AJul 2023$60M
$60M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA))
Jnana Therapeutics
Series CNov 2022$110M
Series ADec 2017$50M
$160M
Co-investors: Amir Nashat (Polaris Partners), Kevin Kinsella (Avalon Ventures)
Nested Therapeutics
SeedJan 2022$35M
$35M
Stablix
Series AJun 2021$63M
$63M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA))
Graphite Bio
Series BMar 2021$150M
Series ASep 2020$45M
$200M
Co-investors: Abe Bassan (Samsara BioCapital), Jerel Davis (Versant Ventures), Jake Simson (RA Capital)
Century Therapeutics
Series CMar 2021$160M
Series AJul 2019$250M
$470M
Co-investors: Eli Casdin (Casdin Capital)
Pandion Therapeutics
Series BApr 2020$80M
Series AJan 2018$58M
$140M
Co-investors: Alan Crane (Polaris Partners), Dan Becker (Access Biotechnology), Vikas Goyal (SR One)
Venatorx Pharmaceuticals
Series BJul 2017$42M
$76M
Co-investors: Brett Zbar (General Atlantic), Martin Heidecker (AMR Action Fund)